✦ LIBER ✦

Cost-effectiveness of liraglutide versus rosiglitazone, both in combination with glimepiride in treatment of type 2 diabetes in the US

✍ Scribed by Lee, W.C.; Conner, C.; Hammer, M.

Book ID: 125844248
Publisher: Informa plc
Year: 2011
Tongue: English
Weight: 311 KB
Volume: 27
Category: Article
ISSN: 0300-7995
DOI: 10.1185/03007995.2011.559444

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Potential benefits of early addition of

Potential benefits of early addition of rosiglitazone in combination with glimepiride in the treatment of type 2 diabetes

✍ J. Rosenstock; H. S. Chou; S. Matthaei; D. K. Seidel; A. Hamann 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 220 KB

DB3 COST-EFFECTIVENESS OF ROSIGLITAZONE-

DB3 COST-EFFECTIVENESS OF ROSIGLITAZONE-METFORMIN COMBINATION IN OVERWEIGHT PATIENTS WITH TYPE 2 DIABETES IN GERMANY

✍ A Shearer; A Bagust; O Schoeffski; U Reitberger; A Goertz; M Behrens 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Results of a model analysis of the cost-

Results of a model analysis of the cost-effectiveness of liraglutide versus exenatide added to metformin, glimepiride, or both for the treatment of type 2 diabetes in the United States

✍ Won Chan Lee; Christopher Conner; Mette Hammer 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 175 KB

PDB26 COST-EFFECTIVENESS OF ROSIGLITAZON

PDB26 COST-EFFECTIVENESS OF ROSIGLITAZONE COMBINATION THERAPY FOR THE TREATMENT OF TYPE 2 DIABETES IN THE CZECH REPUBLIC

✍ T Doležal; J Skoupá; MJ Taylor; S Whitehead; V Rausova; P Pavlikova 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

Antithrombotic Effects of Rosiglitazone-

Antithrombotic Effects of Rosiglitazone-Metformin versus Glimepiride-Metformin Combination Therapy in Patients with Type 2 Diabetes Mellitus and Metabolic Syndrome

✍ Dr. Giuseppe Derosa; Dr. Antonio V. Gaddi; Dr. Mario N. Piccinni; Dr. Leonardina 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

Efficacy and Safety Comparison of Liragl

Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes: The LEAD (Liraglutide Effect and Action in Diabetes)-2 study

✍ Nauck, M.; Frid, A.; Hermansen, K.; Shah, N. S.; Tankova, T.; Mitha, I. H.; Zdra 📂 Article 📅 2008 🏛 American Diabetes Association 🌐 English ⚖ 358 KB